{"gene":"SLC22A12","run_date":"2026-06-10T07:46:32","timeline":{"discoveries":[{"year":2025,"finding":"Cryo-EM structures of native hURAT1 bound with anti-gout drugs (dotinurad, benzbromarone, lesinurad, verinurad) in the inward-open state, and with urate in inward-open, outward-open, and occluded states were solved. Complemented by mutagenesis and cell-based assays, these structures reveal the mechanisms of urate reabsorption and hURAT1 inhibition, providing a structural framework for understanding the transport cycle and drug binding.","method":"Cryo-electron microscopy, site-directed mutagenesis, cell-based transport assays","journal":"Cell discovery","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structures at multiple states, mutagenesis, and cell-based functional validation in a single rigorous study","pmids":["40169562"],"is_preprint":false},{"year":2004,"finding":"PDZK1 interacts with URAT1 via the PDZ motif at the extreme C-terminal intracellular region of URAT1 and the first, second, and fourth PDZ domains of PDZK1. This interaction enhances urate transport activity (1.4-fold increase in Vmax) and increases surface expression of URAT1 at the apical membrane of renal proximal tubular cells.","method":"Yeast two-hybrid screen, in vitro binding assay, surface plasmon resonance, co-immunoprecipitation, colocalization by microscopy, urate transport assays in HEK293 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, SPR binding constants, yeast two-hybrid, functional transport assay, and localization, all in a single study with multiple orthogonal methods","pmids":["15304510"],"is_preprint":false},{"year":2004,"finding":"Loss-of-function mutations in SLC22A12 encoding URAT1 cause renal hypouricemia. URAT1 is the primary reabsorptive urate transporter at the apical membrane of renal proximal tubules and is the target of uricosuric drugs (benzbromarone, probenecid) and the anti-uricosuric drug pyrazinamide in vivo, as demonstrated by pyrazinamide failing to affect urate clearance in homozygous/compound heterozygous SLC22A12 mutant patients.","method":"SLC22A12 gene sequencing in 32 patients, pharmacological loading tests (probenecid, benzbromarone, pyrazinamide), urate clearance measurements","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with defined pharmacological phenotype, gene-dosage effect, replicated across multiple patients and independent studies","pmids":["14694169"],"is_preprint":false},{"year":2011,"finding":"URAT1 expressed in MDCK cells localizes mainly to the apical membrane (as shown by GFP fusion imaging) and mediates time- and dose-dependent urate uptake with a Km of 570.7 µmol/L. Multiple uricosuric drugs (benzbromarone and metabolites, probenecid, indomethacin, salicylate, E3040) inhibit URAT1-mediated urate uptake dose-dependently with IC50 values ranging from 0.05–716 µmol/L.","method":"Stable expression in MDCK cells, urate uptake assays, GFP fusion protein localization by microscopy, pharmacological inhibition studies","journal":"Nephrology (Carlton, Vic.)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional transport assay, multiple drugs characterized in stably expressing cell line","pmids":["21272127"],"is_preprint":false},{"year":2010,"finding":"URAT1 (rUrat1) in rats is localized at the apical membrane of proximal tubular epithelial cells and mediates chloride-susceptible urate transport (Km 1773 µM), inhibited by benzbromarone and trans-stimulated by lactate and pyrazinecarboxylic acid (PZA), consistent with a role in renal urate reabsorption.","method":"Gene expression in Xenopus oocytes, brush-border membrane vesicle (BBMV) transport assays, immunohistochemistry in rat kidney","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution in oocytes, BBMV assays, and immunohistochemical localization with functional characterization","pmids":["21074513"],"is_preprint":false},{"year":2010,"finding":"SLC22A12 (Urat1) knockout mice show significantly higher urinary urate/creatinine ratios than wild-type mice, confirming attenuated renal urate reabsorption via Urat1. However, residual urate reabsorption remains, indicating at least one other urate reabsorptive transporter exists in the mouse kidney.","method":"Gene targeting (exons 1–4 replaced by pMC1neo-polyA), urinary urate/creatinine measurement, plasma urate measurement","journal":"Nucleosides, nucleotides & nucleic acids","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean knockout mouse with defined renal phenotype; negative result (residual reabsorption) also mechanistically informative","pmids":["20544513"],"is_preprint":false},{"year":2010,"finding":"URAT1 missense mutations R406C and G444R found in Iraqi Jewish patients dramatically impair urate uptake into Xenopus oocytes. Additionally, URAT1 facilitates urate efflux (secretion), which was also abolished in the mutants, indicating URAT1 mediates bidirectional urate transport.","method":"Xenopus laevis oocyte transport assays (uptake and efflux) with wild-type and mutant URAT1","journal":"Nephrology, dialysis, transplantation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro transport reconstitution in oocytes with mutagenesis, demonstrating bidirectional transport","pmids":["21148271"],"is_preprint":false},{"year":2010,"finding":"Salicylate is a transport substrate of URAT1 (Km 25.3 µM in oocytes) and also a cis-inhibitor of urate uptake (IC50 23.9 µM in HEK293-URAT1 cells). Salicylate injected into URAT1-expressing oocytes stimulates urate uptake (trans-stimulation), explaining the paradoxical dose-dependent effect of salicylate on renal urate excretion: at low doses, salicylate acts as an exchange substrate facilitating urate reabsorption; at high doses, it competitively inhibits URAT1.","method":"Radiolabeled transport assays in HEK293-URAT1 cells and Xenopus oocytes, trans-stimulation experiments","journal":"Nihon Jinzo Gakkai shi","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct in vitro transport assay in two expression systems with mechanistic kinetic analysis","pmids":["20560471"],"is_preprint":false},{"year":2007,"finding":"Morin competitively inhibits hURAT1-mediated urate uptake in HEK293 cells with IC50 of 2.0 µM and Ki of 5.74 µM. hURAT1 protein is sorted to the apical membrane of transfected cells as confirmed by confocal microscopy.","method":"Transfection of HEK293 cells with hURAT1, radiolabeled urate uptake assays, confocal microscopy of GFP-tagged transporter, kinetic analysis","journal":"Drug metabolism and disposition","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct transport assay with kinetic inhibition analysis and subcellular localization, single lab","pmids":["17325024"],"is_preprint":false},{"year":2016,"finding":"Ancestral URAT1 proteins were computationally inferred, resurrected, and functionally assayed, revealing that URAT1 affinity for uric acid increased during primate evolution, driven by a few amino acid replacements. Human and baboon URAT1 proteins have higher affinity for uric acid than rat and mouse orthologs.","method":"Ancestral sequence reconstruction, resurrection of ancient URAT1 proteins, in vitro transport assays comparing orthologs","journal":"Molecular biology and evolution","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — functional reconstitution of resurrected proteins with transport assays, single lab","pmids":["27352852"],"is_preprint":false},{"year":2004,"finding":"Functional analysis in Xenopus oocytes showed that the SLC22A12 deletion mutation 313A (deletion of residues 313D-333P) has no urate transport activity, identifying it as a loss-of-function mutation causing renal hypouricemia.","method":"Xenopus oocyte expression system with urate transport assay","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct in vitro transport assay in oocytes, single lab and single mutation tested","pmids":["15327384"],"is_preprint":false},{"year":2013,"finding":"URAT1 variants p.G366R, p.L415_G417del, and p.T467M show significantly decreased urate uptake in functional studies and are mislocalized (accumulate in the endoplasmic reticulum rather than the plasma membrane), suggesting loss-of-function via protein misfolding.","method":"Urate uptake assays, immunofluorescence colocalization with ER markers in transfected cells","journal":"European journal of human genetics : EJHG","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transport assay plus subcellular localization, single lab","pmids":["23386035"],"is_preprint":false},{"year":2013,"finding":"URAT1 is expressed on the cilia and apical surface of ventricular ependymal cells lining the lateral ventricle, dorsal/ventral third ventricle, aqueduct, and fourth ventricle in the mouse brain, suggesting a role in regulating urate levels in cerebrospinal fluid.","method":"Immunohistochemistry of wild-type and URAT1 knockout mouse brain; specificity confirmed by absence of staining in knockout","journal":"Fluids and barriers of the CNS","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with KO-validated antibody specificity, single lab, functional significance inferred","pmids":["24156345"],"is_preprint":false},{"year":2004,"finding":"The hURAT1 gene promoter was cloned and the transcription initiation site mapped 337 bp upstream of the ATG start codon. The minimal functional promoter is within 253 bp. Testosterone significantly increases promoter activity, suggesting hormonal regulation underlies sex-related differences in urate levels.","method":"Primer extension, 5'-RACE, promoter-luciferase reporter constructs transfected in OK cells, testosterone stimulation","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional promoter assay with hormone stimulation, single lab","pmids":["15566944"],"is_preprint":false},{"year":2018,"finding":"Genetic and pharmacological inhibition of SGLT2 enhanced fractional renal urate excretion in mice. URAT1 knockout mice demonstrated that URAT1 is required for the acute uricosuric effect of the SGLT2 inhibitor canagliflozin, placing URAT1 downstream in the luminal glucose-mediated uricosuric mechanism.","method":"Gene-targeted mouse models (Urat1-KO, Sglt2-KO, Sglt1-KO, Glut9 tubular KO), SGLT2 inhibitor treatment, renal clearance studies","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in multiple KO models, single lab","pmids":["30427222"],"is_preprint":false},{"year":2021,"finding":"URAT1 is expressed in the liver and brown adipose tissue (BAT) in addition to the kidney. In high-fat diet mice, URAT1 expression increased in BAT. Pharmacological inhibition with dotinurad (a URAT1-selective inhibitor) attenuated hepatic steatosis and BAT whitening via UCP1 activation, ameliorating insulin resistance.","method":"Western blot for URAT1 expression in liver and BAT, dotinurad treatment of HFD mice, metabolic phenotyping","journal":"Molecular metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct expression localization plus pharmacological inhibition with metabolic readouts, single lab","pmids":["34863940"],"is_preprint":false},{"year":2023,"finding":"URAT1 is expressed in cardiomyocytes and functions as a uric acid transporter in this cell type. Palmitic acid increases URAT1 expression in neonatal rat cardiomyocytes and induces apoptosis, oxidative stress, and inflammatory responses via the MAPK pathway; URAT1-selective inhibition with dotinurad attenuates these effects.","method":"Western blot and functional transport assay in cardiomyocytes, palmitic acid stimulation, dotinurad treatment, HFD mouse model","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — expression and functional data in cardiomyocytes, pharmacological inhibition with pathway readout, single lab","pmids":["37694143"],"is_preprint":false},{"year":2025,"finding":"URAT1 cell-surface abundance and urate transport activity are regulated by phosphorylation of URAT1 at Thr408, stimulated by hyperinsulinemia via AKT kinase. SGK1, induced by high salt, also phosphorylates URAT1-Thr408 via the same pathway, increasing URAT1 activity. Arg405 is essential for these kinases to phosphorylate URAT1-Thr408.","method":"Kinase screening, single-cell data analysis, cell culture experiments with AKT/SGK1 inhibition and activation, URAT1 mutagenesis (Arg405, Thr408), urate transport assays in transfected cells","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — kinase screening, mutagenesis of phosphorylation site, functional transport assays, and large human cohort validation; multiple orthogonal methods in one study","pmids":["40100301"],"is_preprint":false},{"year":2020,"finding":"Xanthine (but not hypoxanthine) is a substrate of URAT1, as demonstrated by uptake assays in URAT1-expressing Xenopus oocytes. Transcellular transport of xanthine in MDCKII cells co-expressing URAT1 and GLUT9 was significantly higher than in cells expressing either transporter alone or mock cells, indicating cooperative reabsorption.","method":"Radiolabeled xanthine/hypoxanthine uptake assays in Xenopus oocytes expressing URAT1 or GLUT9; transcellular transport in MDCKII cells; in vivo renal clearance in rats with dotinurad","journal":"Biological & pharmaceutical bulletin","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct substrate identification in oocyte reconstitution system, single lab, confirmed with in vivo data","pmids":["33132325"],"is_preprint":false},{"year":2021,"finding":"Loss of Urat1/Rst in knockout mice leads to disrupted redox homeostasis, with accumulation of metabolites related to pyrimidine, fatty acid, and amino acid metabolism distinct from Oat1 and Oat3 knockouts. Systems metabolic analysis revealed compensatory processes related to reactive oxygen species handling via Vitamin C metabolism and cofactor charging reactions.","method":"Metabolomics of Urat1 knockout mice, transcriptomics, genome-scale metabolic modeling (GEM), chemoinformatics","journal":"Antioxidants (Basel, Switzerland)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO model with multi-omics phenotyping and systems analysis, single lab","pmids":["36979028"],"is_preprint":false},{"year":2021,"finding":"In Urat1-Uox double knockout mice, exercise-induced AKI is associated with increased NLRP3 inflammasome activity (elevated IL-1β) and downregulation of Na+-K+-ATPase in the kidney. Xanthine oxidoreductase inhibitors (topiroxostat and allopurinol) improved renal injury and prevented EIAKI in these mice.","method":"Double KO mice (Urat1-Uox), forced swimming exercise test, Western blot for NLRP3, Na+-K+-ATPase, IL-1β; XOI treatment","journal":"Journal of the American Society of Nephrology : JASN","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic model with defined molecular pathway via Western blot and pharmacological rescue, single lab","pmids":["34799437"],"is_preprint":false},{"year":2017,"finding":"ALPK1 overexpression in transgenic mice decreased renal URAT1 protein levels, and MSU crystals inhibited URAT1 expression through upregulation of ALPK1 in human kidney-2 cells, establishing ALPK1 as a negative regulator of URAT1 protein expression.","method":"ALPK1 transgenic mice (URAT1 protein by Western blot), ALPK1 siRNA knockdown in HK-2 cells with MSU crystal stimulation","journal":"Rheumatology (Oxford, England)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, Western blot for protein level only, mechanism of regulation not detailed","pmids":["28039413"],"is_preprint":false},{"year":2011,"finding":"In leptin-deficient (ob/ob) and high-fat diet mice, URAT1 (Slc22a12) protein levels are increased in the kidney without significant changes in mRNA, suggesting post-translational regulation of URAT1 protein abundance in obesity.","method":"Western blot and RT-PCR of kidney tissue from ob/ob and high-fat diet mouse models","journal":"Nucleosides, nucleotides & nucleic acids","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, correlational protein/mRNA measurement without mechanistic follow-up","pmids":["22132989"],"is_preprint":false},{"year":2020,"finding":"Long-chain unsaturated omega-3 fatty acids (eicosapentaenoic acid IC50 6.0 µM, α-linolenic acid IC50 14.2 µM, docosahexaenoic acid IC50 15.2 µM) inhibit URAT1-mediated urate transport more potently than saturated fatty acids, as determined in cells transiently expressing URAT1.","method":"In vitro transport assay using cells transiently expressing URAT1, IC50 determination for 25 fatty acids","journal":"Nutrients","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic in vitro inhibition screen with IC50 values across multiple substrates, single lab","pmids":["32486008"],"is_preprint":false},{"year":2020,"finding":"Rare SLC22A12 variants that reduce URAT1 urate transport activity account for >10% of heritability in serum urate levels (missing heritability), as demonstrated by functional transport assays on identified rare variants combined with population genetic analysis.","method":"Whole genome sequencing (ToMMo cohort), functional urate uptake assays on identified rare variants, variance component analysis","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transport assays on variants combined with population genetics, single lab","pmids":["32005656"],"is_preprint":false}],"current_model":"URAT1 (SLC22A12) is a urate-anion exchanger localized at the apical membrane of renal proximal tubular cells that mediates the majority of renal urate reabsorption via an electroneutral exchange mechanism; its transport activity is regulated by AKT/SGK1-mediated phosphorylation at Thr408 (stimulated by hyperinsulinemia and high salt), enhanced by interaction with the scaffold protein PDZK1 (which increases surface expression and Vmax), and inhibited competitively by uricosuric drugs (benzbromarone, probenecid, lesinurad, dotinurad, verinurad) whose binding modes have been resolved by cryo-EM structures in multiple conformational states; URAT1 also transports salicylate and xanthine as substrates, is additionally expressed in ependymal cells, cardiomyocytes, liver, and brown adipose tissue, and loss-of-function mutations cause renal hypouricemia type 1."},"narrative":{"mechanistic_narrative":"SLC22A12 (URAT1) is the principal apical urate-anion exchanger of the renal proximal tubule and the central determinant of renal urate reabsorption [PMID:14694169, PMID:21272127]. It mediates electrogenic, chloride-sensitive urate transport that is bidirectional, supporting both reabsorptive uptake and efflux, and is trans-stimulated by intracellular monocarboxylates such as lactate and pyrazinecarboxylate [PMID:21074513, PMID:21148271]. Cryo-EM structures captured in inward-open, outward-open, and occluded states define the transport cycle and the binding modes of urate and uricosuric inhibitors [PMID:40169562]. Beyond urate, URAT1 transports salicylate and xanthine, the latter cooperatively with GLUT9 in transcellular assays; salicylate behaves as both an exchange substrate (trans-stimulating reabsorption at low dose) and a competitive inhibitor at high dose [PMID:20560471, PMID:33132325]. Transport activity is tuned post-translationally: PDZK1 binds the C-terminal PDZ motif of URAT1 to raise apical surface expression and Vmax [PMID:15304510], while AKT and high-salt-induced SGK1 phosphorylate URAT1 at Thr408 (dependent on Arg405) to increase surface abundance and activity [PMID:40100301]. Loss-of-function mutations in SLC22A12 cause renal hypouricemia type 1, frequently through impaired transport or ER retention of misfolded protein [PMID:14694169, PMID:23386035]. Although best characterized in kidney, URAT1 is also expressed in ependymal cilia, cardiomyocytes, liver, and brown adipose tissue, where its activity has been linked to local metabolic and inflammatory responses [PMID:24156345, PMID:34863940, PMID:37694143].","teleology":[{"year":2004,"claim":"Establishing that URAT1 is the primary renal reabsorptive urate transporter and the in vivo target of uricosuric and anti-uricosuric drugs converted a candidate transporter into the genetic and pharmacological linchpin of urate handling.","evidence":"SLC22A12 sequencing in renal hypouricemia patients with pharmacological loading tests (probenecid, benzbromarone, pyrazinamide)","pmids":["14694169"],"confidence":"High","gaps":["Did not resolve the exchange mechanism or counter-ion at molecular level","Residual reabsorption pathway not identified"]},{"year":2004,"claim":"Identifying PDZK1 as a scaffold partner answered how URAT1 is held at and enriched on the apical membrane, linking trafficking to transport capacity.","evidence":"Yeast two-hybrid, SPR, reciprocal Co-IP, colocalization, and urate transport assays in HEK293 cells","pmids":["15304510"],"confidence":"High","gaps":["Vmax increase modest (1.4-fold); physiological magnitude in vivo unclear","Whether PDZK1 regulation is dynamically modulated not addressed"]},{"year":2004,"claim":"Mapping the promoter and showing testosterone-stimulated activity provided a transcriptional basis for sex differences in serum urate.","evidence":"Primer extension, 5'-RACE, and promoter-luciferase reporters with testosterone stimulation in OK cells","pmids":["15566944"],"confidence":"Medium","gaps":["Direct transcription factor mediating testosterone response not identified","In vivo relevance to human sex differences not established"]},{"year":2010,"claim":"Oocyte and BBMV reconstitution defined URAT1 as a chloride-sensitive, monocarboxylate trans-stimulated urate transporter, and knockout mice confirmed its role while revealing a second reabsorptive pathway.","evidence":"Xenopus oocyte and brush-border vesicle transport assays, immunohistochemistry, and Urat1 knockout mouse urinary phenotyping","pmids":["21074513","20544513","21148271"],"confidence":"High","gaps":["Identity of the residual urate reabsorptive transporter unknown","Endogenous counter-substrate driving exchange in vivo not defined"]},{"year":2010,"claim":"Demonstrating salicylate as both a transported substrate and a dose-dependent modulator explained the long-standing paradox of biphasic salicylate effects on urate excretion.","evidence":"Radiolabeled transport and trans-stimulation assays in HEK293-URAT1 and Xenopus oocytes","pmids":["20560471"],"confidence":"High","gaps":["Structural basis of dual substrate/inhibitor behavior not resolved at this stage"]},{"year":2013,"claim":"Showing that disease mutants are retained in the ER established protein misfolding/mistrafficking as a mechanism of loss-of-function, beyond simple loss of intrinsic transport.","evidence":"Urate uptake assays plus immunofluorescence colocalization with ER markers for p.G366R, p.L415_G417del, p.T467M","pmids":["23386035"],"confidence":"Medium","gaps":["Whether folding can be pharmacologically rescued untested","Generality across all hypouricemia variants unknown"]},{"year":2013,"claim":"Detecting URAT1 on ependymal cilia broadened its role beyond kidney to potential CSF urate regulation.","evidence":"KO-validated immunohistochemistry of mouse brain ventricular surfaces","pmids":["24156345"],"confidence":"Medium","gaps":["Functional transport at ependyma not directly measured","Physiological consequence for CSF urate unestablished"]},{"year":2016,"claim":"Ancestral resurrection showed URAT1 urate affinity rose during primate evolution, framing high urate reabsorption as a derived primate trait.","evidence":"Ancestral sequence reconstruction and transport assays comparing resurrected and extant orthologs","pmids":["27352852"],"confidence":"Medium","gaps":["Selective advantage driving affinity increase inferred, not demonstrated","Specific residues only partially mapped"]},{"year":2020,"claim":"Extending the substrate repertoire to xanthine and showing GLUT9 cooperativity, plus population-scale rare-variant analysis, connected URAT1 transport directly to heritable serum urate variation.","evidence":"Oocyte/MDCKII transcellular xanthine assays and functional assays on rare variants from whole-genome sequencing with variance component analysis","pmids":["33132325","32005656"],"confidence":"Medium","gaps":["Physiological importance of xanthine transport relative to urate unclear","Functional effect of many rare variants still uncharacterized"]},{"year":2025,"claim":"Cryo-EM in multiple conformational states and identification of AKT/SGK1 phosphorylation at Thr408 together provided the structural transport cycle and a signaling mechanism linking hyperinsulinemia and salt to elevated urate.","evidence":"Cryo-EM with mutagenesis and transport assays; kinase screening, phospho-site mutagenesis (Arg405, Thr408), and human cohort validation","pmids":["40169562","40100301"],"confidence":"High","gaps":["Phosphatase counter-regulating Thr408 not identified","Structures of phosphorylated state not resolved","Integration of PDZK1 scaffolding into structural model incomplete"]},{"year":null,"claim":"How URAT1 contributes mechanistically to extrarenal tissues (cardiomyocyte injury, hepatic steatosis, BAT thermogenesis, redox homeostasis) and how its surface abundance is dynamically controlled remain incompletely defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Direct transport function in liver/BAT not measured in situ","Causal chain from URAT1 activity to MAPK/NLRP3/UCP1 outcomes unresolved","Mechanisms of post-translational protein-level regulation in obesity not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[2,3,4,6,7,18]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[4,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,4,8]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[12]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[11]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2,3,4,18]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[7,18]}],"complexes":[],"partners":["PDZK1","GLUT9"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q96S37","full_name":"Solute carrier family 22 member 12","aliases":["Organic anion transporter 4-like protein","Renal-specific transporter","RST","Urate anion exchanger 1","URAT1","Urate:anion antiporter SLC22A12"],"length_aa":553,"mass_kda":59.6,"function":"Electroneutral antiporter that translocates urate across the apical membrane of proximal tubular cells in exchange for monovalent organic or inorganic anions (PubMed:12024214, PubMed:22194875, PubMed:35144162, PubMed:35462902). Involved in renal reabsorption of urate and helps maintaining blood levels of uric acid (PubMed:12024214, PubMed:22194875). Mediates urate uptake by an exchange with organic anions such as (S)-lactate and nicotinate, and inorganic anion Cl(-) (PubMed:12024214). Other inorganic anions such as Br(-), I(-) and NO3(-) may also act as counteranions that exchange for urate (PubMed:12024214). Also mediates orotate tubular uptake coupled with nicotinate efflux and to a lesser extent with lactate efflux, therefore displaying a potential role in orotate renal reabsorption (PubMed:21350910). Orotate transport is Cl(-)-dependent (PubMed:21350910)","subcellular_location":"Apical cell membrane","url":"https://www.uniprot.org/uniprotkb/Q96S37/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC22A12","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC22A12","total_profiled":1310},"omim":[{"mim_id":"612455","title":"SOLUTE CARRIER FAMILY 5 (SODIUM/GLUCOSE COTRANSPORTER), MEMBER 12; SLC5A12","url":"https://www.omim.org/entry/612455"},{"mim_id":"612076","title":"HYPOURICEMIA, RENAL, 2; RHUC2","url":"https://www.omim.org/entry/612076"},{"mim_id":"608044","title":"SOLUTE CARRIER FAMILY 5 (IODIDE TRANSPORTER), MEMBER 8; SLC5A8","url":"https://www.omim.org/entry/608044"},{"mim_id":"607096","title":"SOLUTE CARRIER FAMILY 22 (URATE TRANSPORTER), MEMBER 12; SLC22A12","url":"https://www.omim.org/entry/607096"},{"mim_id":"606142","title":"SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 9; SLC2A9","url":"https://www.omim.org/entry/606142"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"kidney","ntpm":103.6}],"url":"https://www.proteinatlas.org/search/SLC22A12"},"hgnc":{"alias_symbol":["OAT4L","RST","URAT1","hURAT1","UAT"],"prev_symbol":[]},"alphafold":{"accession":"Q96S37","domains":[{"cath_id":"1.20.1250.20","chopping":"2-40_152-325","consensus_level":"medium","plddt":90.3374,"start":2,"end":325},{"cath_id":"-","chopping":"48-123","consensus_level":"high","plddt":81.7112,"start":48,"end":123},{"cath_id":"1.20.1250.20","chopping":"336-535","consensus_level":"medium","plddt":87.947,"start":336,"end":535}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96S37","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96S37-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96S37-F1-predicted_aligned_error_v6.png","plddt_mean":86.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC22A12","jax_strain_url":"https://www.jax.org/strain/search?query=SLC22A12"},"sequence":{"accession":"Q96S37","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96S37.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96S37/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96S37"}},"corpus_meta":[{"pmid":"14694169","id":"PMC_14694169","title":"Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion.","date":"2004","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/14694169","citation_count":297,"is_preprint":false},{"pmid":"11684659","id":"PMC_11684659","title":"rst and its paralogue kirre act redundantly during embryonic muscle development in Drosophila.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11684659","citation_count":176,"is_preprint":false},{"pmid":"15304510","id":"PMC_15304510","title":"The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15304510","citation_count":152,"is_preprint":false},{"pmid":"30427222","id":"PMC_30427222","title":"SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.","date":"2018","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30427222","citation_count":140,"is_preprint":false},{"pmid":"7646884","id":"PMC_7646884","title":"Restricted expression of the irreC-rst protein is required for normal axonal projections of columnar visual neurons.","date":"1995","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/7646884","citation_count":110,"is_preprint":false},{"pmid":"25739858","id":"PMC_25739858","title":"Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia.","date":"2015","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/25739858","citation_count":101,"is_preprint":false},{"pmid":"15327384","id":"PMC_15327384","title":"A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese.","date":"2004","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/15327384","citation_count":95,"is_preprint":false},{"pmid":"20226034","id":"PMC_20226034","title":"The RST and PARP-like domain containing SRO protein family: analysis of protein structure, function and conservation in land plants.","date":"2010","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20226034","citation_count":85,"is_preprint":false},{"pmid":"21272127","id":"PMC_21272127","title":"Interactions of urate transporter URAT1 in human kidney with uricosuric drugs.","date":"2011","source":"Nephrology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/21272127","citation_count":84,"is_preprint":false},{"pmid":"18492088","id":"PMC_18492088","title":"Age and origin of the G774A mutation in SLC22A12 causing renal hypouricemia in Japanese.","date":"2008","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18492088","citation_count":79,"is_preprint":false},{"pmid":"8674431","id":"PMC_8674431","title":"Reorganization of membrane contacts prior to apoptosis in the Drosophila retina: the role of the IrreC-rst protein.","date":"1996","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8674431","citation_count":78,"is_preprint":false},{"pmid":"12144699","id":"PMC_12144699","title":"Differential expression and induction of two Drosophila cytochrome P450 genes near the Rst(2)DDT locus.","date":"2002","source":"Insect molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12144699","citation_count":77,"is_preprint":false},{"pmid":"34044255","id":"PMC_34044255","title":"Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.","date":"2021","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34044255","citation_count":72,"is_preprint":false},{"pmid":"15054642","id":"PMC_15054642","title":"The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia.","date":"2004","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/15054642","citation_count":68,"is_preprint":false},{"pmid":"27352852","id":"PMC_27352852","title":"Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout.","date":"2016","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/27352852","citation_count":67,"is_preprint":false},{"pmid":"16837472","id":"PMC_16837472","title":"Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout.","date":"2006","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16837472","citation_count":63,"is_preprint":false},{"pmid":"16164626","id":"PMC_16164626","title":"Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].","date":"2005","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16164626","citation_count":61,"is_preprint":false},{"pmid":"11140597","id":"PMC_11140597","title":"[D-Leu1]Microcystin-LR, from the cyanobacterium Microcystis RST 9501 and from a Microcystis bloom in the Patos Lagoon estuary, Brazil.","date":"2000","source":"Phytochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11140597","citation_count":59,"is_preprint":false},{"pmid":"16920156","id":"PMC_16920156","title":"Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese.","date":"2006","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16920156","citation_count":57,"is_preprint":false},{"pmid":"34863940","id":"PMC_34863940","title":"URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice.","date":"2021","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34863940","citation_count":52,"is_preprint":false},{"pmid":"31593642","id":"PMC_31593642","title":"Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019).","date":"2019","source":"Expert opinion on therapeutic patents","url":"https://pubmed.ncbi.nlm.nih.gov/31593642","citation_count":52,"is_preprint":false},{"pmid":"22194875","id":"PMC_22194875","title":"Clinical and functional characterization of URAT1 variants.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22194875","citation_count":51,"is_preprint":false},{"pmid":"21148271","id":"PMC_21148271","title":"URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews.","date":"2010","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/21148271","citation_count":50,"is_preprint":false},{"pmid":"15788453","id":"PMC_15788453","title":"IrreC/rst-mediated cell sorting during Drosophila pupal eye development depends on proper localisation of DE-cadherin.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15788453","citation_count":49,"is_preprint":false},{"pmid":"14758072","id":"PMC_14758072","title":"Galectin 9 is the sugar-regulated urate transporter/channel UAT.","date":"2002","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/14758072","citation_count":47,"is_preprint":false},{"pmid":"23386035","id":"PMC_23386035","title":"Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis.","date":"2013","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/23386035","citation_count":47,"is_preprint":false},{"pmid":"34216576","id":"PMC_34216576","title":"A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications.","date":"2021","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34216576","citation_count":46,"is_preprint":false},{"pmid":"25535087","id":"PMC_25535087","title":"Effects of Xie-Zhuo-Chu-Bi-Fang on miR-34a and URAT1 and their relationship in hyperuricemic mice.","date":"2014","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25535087","citation_count":44,"is_preprint":false},{"pmid":"29990831","id":"PMC_29990831","title":"Research on the pharmacodynamics and mechanism of Fraxini Cortex on hyperuricemia based on the regulation of URAT1 and GLUT9.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29990831","citation_count":44,"is_preprint":false},{"pmid":"26500098","id":"PMC_26500098","title":"Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.","date":"2015","source":"Clinical and experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/26500098","citation_count":44,"is_preprint":false},{"pmid":"29486147","id":"PMC_29486147","title":"URAT1 and GLUT9 mutations in Spanish patients with renal hypouricemia.","date":"2018","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29486147","citation_count":42,"is_preprint":false},{"pmid":"26821810","id":"PMC_26821810","title":"The effects of URAT1/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26821810","citation_count":42,"is_preprint":false},{"pmid":"33922488","id":"PMC_33922488","title":"Fucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells.","date":"2021","source":"Marine drugs","url":"https://pubmed.ncbi.nlm.nih.gov/33922488","citation_count":42,"is_preprint":false},{"pmid":"27906637","id":"PMC_27906637","title":"Prevalence of URAT1 allelic variants in the Roma population.","date":"2016","source":"Nucleosides, nucleotides & nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/27906637","citation_count":39,"is_preprint":false},{"pmid":"25267580","id":"PMC_25267580","title":"Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice.","date":"2014","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25267580","citation_count":38,"is_preprint":false},{"pmid":"25268603","id":"PMC_25268603","title":"Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25268603","citation_count":36,"is_preprint":false},{"pmid":"32283759","id":"PMC_32283759","title":"Uric Acid Has Direct Proinflammatory Effects on Human Macrophages by Increasing Proinflammatory Mediators and Bacterial Phagocytosis Probably via URAT1.","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/32283759","citation_count":36,"is_preprint":false},{"pmid":"26603249","id":"PMC_26603249","title":"Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1.","date":"2015","source":"BMJ open","url":"https://pubmed.ncbi.nlm.nih.gov/26603249","citation_count":32,"is_preprint":false},{"pmid":"26033041","id":"PMC_26033041","title":"High frequency of SLC22A12 variants causing renal hypouricemia 1 in the Czech and Slovak Roma population; simple and rapid detection method by allele-specific polymerase chain reaction.","date":"2015","source":"Urolithiasis","url":"https://pubmed.ncbi.nlm.nih.gov/26033041","citation_count":32,"is_preprint":false},{"pmid":"21074513","id":"PMC_21074513","title":"Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21074513","citation_count":30,"is_preprint":false},{"pmid":"32486008","id":"PMC_32486008","title":"Omega-3 Polyunsaturated Fatty Acids Inhibit the Function of Human URAT1, a Renal Urate Re-Absorber.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32486008","citation_count":29,"is_preprint":false},{"pmid":"19833602","id":"PMC_19833602","title":"Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese.","date":"2009","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19833602","citation_count":28,"is_preprint":false},{"pmid":"15566944","id":"PMC_15566944","title":"Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15566944","citation_count":28,"is_preprint":false},{"pmid":"32083126","id":"PMC_32083126","title":"Hypouricemic Effects of Extracts from Urtica hyperborea Jacq. ex Wedd. in Hyperuricemia Mice through XOD, URAT1, and OAT1.","date":"2020","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/32083126","citation_count":28,"is_preprint":false},{"pmid":"15772829","id":"PMC_15772829","title":"Recurrent URAT1 gene mutations and prevalence of renal hypouricemia in Japanese.","date":"2005","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/15772829","citation_count":28,"is_preprint":false},{"pmid":"17067649","id":"PMC_17067649","title":"Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus.","date":"2006","source":"Toxicon : official journal of the International Society on Toxinology","url":"https://pubmed.ncbi.nlm.nih.gov/17067649","citation_count":28,"is_preprint":false},{"pmid":"20544513","id":"PMC_20544513","title":"Establishment and analysis of SLC22A12 (URAT1) knockout mouse.","date":"2010","source":"Nucleosides, nucleotides & nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/20544513","citation_count":27,"is_preprint":false},{"pmid":"22688828","id":"PMC_22688828","title":"Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.","date":"2012","source":"Kidney & blood pressure research","url":"https://pubmed.ncbi.nlm.nih.gov/22688828","citation_count":27,"is_preprint":false},{"pmid":"17325024","id":"PMC_17325024","title":"Morin (3,5,7,2',4'-pentahydroxyflavone) exhibits potent inhibitory actions on urate transport by the human urate anion transporter (hURAT1) expressed in human embryonic kidney cells.","date":"2007","source":"Drug metabolism and disposition: the biological fate of chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/17325024","citation_count":27,"is_preprint":false},{"pmid":"22132989","id":"PMC_22132989","title":"The increased protein level of URAT1 was observed in obesity/metabolic syndrome model mice.","date":"2011","source":"Nucleosides, nucleotides & nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/22132989","citation_count":26,"is_preprint":false},{"pmid":"19019168","id":"PMC_19019168","title":"Prevalence of hypouricaemia and SLC22A12 mutations in healthy Korean subjects.","date":"2008","source":"Nephrology (Carlton, Vic.)","url":"https://pubmed.ncbi.nlm.nih.gov/19019168","citation_count":25,"is_preprint":false},{"pmid":"29740170","id":"PMC_29740170","title":"Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST™).","date":"2018","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29740170","citation_count":25,"is_preprint":false},{"pmid":"38498316","id":"PMC_38498316","title":"Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway.","date":"2024","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38498316","citation_count":23,"is_preprint":false},{"pmid":"10978286","id":"PMC_10978286","title":"A screen for dominant modifiers of the irreC-rst cell death phenotype in the developing Drosophila retina.","date":"2000","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10978286","citation_count":23,"is_preprint":false},{"pmid":"16703794","id":"PMC_16703794","title":"Analysis of mutations in the urate transporter 1 (URAT1) gene of Japanese patients with hypouricemia in northern Japan and review of the literature.","date":"2006","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/16703794","citation_count":22,"is_preprint":false},{"pmid":"36753966","id":"PMC_36753966","title":"Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.","date":"2023","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36753966","citation_count":22,"is_preprint":false},{"pmid":"18824160","id":"PMC_18824160","title":"T6092C polymorphism of SLC22A12 gene is associated with serum uric acid concentrations in Korean male subjects.","date":"2008","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18824160","citation_count":22,"is_preprint":false},{"pmid":"32005656","id":"PMC_32005656","title":"Contribution of Rare Variants of the SLC22A12 Gene to the Missing Heritability of Serum Urate Levels.","date":"2020","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32005656","citation_count":22,"is_preprint":false},{"pmid":"23043931","id":"PMC_23043931","title":"Novel URAT1 mutations caused acute renal failure after exercise in two Chinese families with renal hypouricemia.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23043931","citation_count":22,"is_preprint":false},{"pmid":"34799437","id":"PMC_34799437","title":"Xanthine Oxidoreductase Inhibitors Suppress the Onset of Exercise-Induced AKI in High HPRT Activity Urat1-Uox Double Knockout Mice.","date":"2021","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/34799437","citation_count":21,"is_preprint":false},{"pmid":"27906636","id":"PMC_27906636","title":"Urat1-Uox double knockout mice are experimental animal models of renal hypouricemia and exercise-induced acute kidney injury.","date":"2016","source":"Nucleosides, nucleotides & nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/27906636","citation_count":21,"is_preprint":false},{"pmid":"24156345","id":"PMC_24156345","title":"Ependymal cells of the mouse brain express urate transporter 1 (URAT1).","date":"2013","source":"Fluids and barriers of the CNS","url":"https://pubmed.ncbi.nlm.nih.gov/24156345","citation_count":21,"is_preprint":false},{"pmid":"36710339","id":"PMC_36710339","title":"Hyperuricemia exacerbates abdominal aortic aneurysm formation through the URAT1/ERK/MMP-9 signaling pathway.","date":"2023","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/36710339","citation_count":20,"is_preprint":false},{"pmid":"28499081","id":"PMC_28499081","title":"Negative correlation between serum uric acid and kidney URAT1 mRNA expression caused by resveratrol in rats.","date":"2017","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/28499081","citation_count":20,"is_preprint":false},{"pmid":"16380111","id":"PMC_16380111","title":"The adaptor protein X11Lalpha/Dmint1 interacts with the PDZ-binding domain of the cell recognition protein Rst in Drosophila.","date":"2005","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16380111","citation_count":20,"is_preprint":false},{"pmid":"27951420","id":"PMC_27951420","title":"(E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27951420","citation_count":18,"is_preprint":false},{"pmid":"31882426","id":"PMC_31882426","title":"Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.","date":"2019","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/31882426","citation_count":17,"is_preprint":false},{"pmid":"33132325","id":"PMC_33132325","title":"Renal Reabsorptive Transport of Uric Acid Precursor Xanthine by URAT1 and GLUT9.","date":"2020","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/33132325","citation_count":17,"is_preprint":false},{"pmid":"22609918","id":"PMC_22609918","title":"Two surfaces of a conserved interdomain linker differentially affect output from the RST sensing module of the Bacillus subtilis stressosome.","date":"2012","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/22609918","citation_count":17,"is_preprint":false},{"pmid":"28039413","id":"PMC_28039413","title":"URAT1 inhibition by ALPK1 is associated with uric acid homeostasis.","date":"2017","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28039413","citation_count":16,"is_preprint":false},{"pmid":"38556118","id":"PMC_38556118","title":"Protecting against ferroptosis in hyperuricemic nephropathy: The potential of ferrostatin-1 and its inhibitory effect on URAT1.","date":"2024","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38556118","citation_count":16,"is_preprint":false},{"pmid":"35276934","id":"PMC_35276934","title":"Identification of Inhibitory Activities of Dietary Flavonoids against URAT1, a Renal Urate Re-Absorber: In Vitro Screening and Fractional Approach Focused on Rooibos Leaves.","date":"2022","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/35276934","citation_count":16,"is_preprint":false},{"pmid":"30097038","id":"PMC_30097038","title":"Renal hypouricemia caused by novel compound heterozygous mutations in the SLC22A12 gene: a case report with literature review.","date":"2018","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30097038","citation_count":16,"is_preprint":false},{"pmid":"35083262","id":"PMC_35083262","title":"The Active Components of Sunflower (Helianthus annuus L.) Calathide and the Effects on Urate Nephropathy Based on COX-2/PGE2 Signaling Pathway and the Urate Transporter URAT1, ABCG2, and GLUT9.","date":"2022","source":"Frontiers in nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/35083262","citation_count":15,"is_preprint":false},{"pmid":"27225847","id":"PMC_27225847","title":"Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27225847","citation_count":15,"is_preprint":false},{"pmid":"27955673","id":"PMC_27955673","title":"Immunohistochemical and in situ hybridization study of urate transporters GLUT9/URATv1, ABCG2, and URAT1 in the murine brain.","date":"2016","source":"Fluids and barriers of the CNS","url":"https://pubmed.ncbi.nlm.nih.gov/27955673","citation_count":15,"is_preprint":false},{"pmid":"17891652","id":"PMC_17891652","title":"Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia.","date":"2007","source":"Scandinavian journal of clinical and laboratory investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17891652","citation_count":15,"is_preprint":false},{"pmid":"19306160","id":"PMC_19306160","title":"High-resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China.","date":"2009","source":"Scandinavian journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/19306160","citation_count":15,"is_preprint":false},{"pmid":"14527196","id":"PMC_14527196","title":"A study of Y-chromosome microsatellite variation in sub-Saharan Africa: a comparison between F(ST) and R(ST) genetic distances.","date":"2003","source":"Human biology","url":"https://pubmed.ncbi.nlm.nih.gov/14527196","citation_count":15,"is_preprint":false},{"pmid":"33821957","id":"PMC_33821957","title":"Substantial anti-gout effect conferred by common and rare dysfunctional variants of URAT1/SLC22A12.","date":"2021","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33821957","citation_count":14,"is_preprint":false},{"pmid":"34775203","id":"PMC_34775203","title":"Novel natural scaffold as hURAT1 inhibitor identified by 3D-shape-based, docking-based virtual screening approach and biological evaluation.","date":"2021","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34775203","citation_count":14,"is_preprint":false},{"pmid":"20560471","id":"PMC_20560471","title":"[Human renal urate transpoter URAT1 mediates the transport of salicylate].","date":"2010","source":"Nihon Jinzo Gakkai shi","url":"https://pubmed.ncbi.nlm.nih.gov/20560471","citation_count":14,"is_preprint":false},{"pmid":"36986518","id":"PMC_36986518","title":"Ethanolic Extract from Limonia acidissima L. Fruit Attenuates Serum Uric Acid Level via URAT1 in Potassium Oxonate-Induced Hyperuricemic Rats.","date":"2023","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36986518","citation_count":13,"is_preprint":false},{"pmid":"26433599","id":"PMC_26433599","title":"Characteristics of Recombinant Phytase (rSt-Phy) of the Thermophilic mold Sporotrichum thermophile and its applicability in dephytinizing foods.","date":"2015","source":"Applied biochemistry and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/26433599","citation_count":13,"is_preprint":false},{"pmid":"19019900","id":"PMC_19019900","title":"The effects of acute dynamic exercise on haemostasis in fi rst class Scottish football referees.","date":"2010","source":"British journal of sports medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19019900","citation_count":13,"is_preprint":false},{"pmid":"38669781","id":"PMC_38669781","title":"Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia.","date":"2024","source":"Bioorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38669781","citation_count":12,"is_preprint":false},{"pmid":"21857931","id":"PMC_21857931","title":"rst transcriptional activity influences kirre mRNA concentration in the Drosophila pupal retina during the final steps of ommatidial patterning.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21857931","citation_count":12,"is_preprint":false},{"pmid":"29843128","id":"PMC_29843128","title":"Zurampic Protects Pancreatic β-Cells from High Uric Acid Induced-Damage by Inhibiting URAT1 and Inactivating the ROS/AMPK/ERK Pathways.","date":"2018","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29843128","citation_count":12,"is_preprint":false},{"pmid":"40169562","id":"PMC_40169562","title":"Molecular mechanisms of urate transport by the native human URAT1 and its inhibition by anti-gout drugs.","date":"2025","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/40169562","citation_count":11,"is_preprint":false},{"pmid":"34255816","id":"PMC_34255816","title":"Genetic epidemiological analysis of hypouricaemia from 4993 Japanese on non-functional variants of URAT1/SLC22A12 gene.","date":"2022","source":"Rheumatology (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34255816","citation_count":11,"is_preprint":false},{"pmid":"37694143","id":"PMC_37694143","title":"URAT1 is expressed in cardiomyocytes and dotinurad attenuates the development of diet-induced metabolic heart disease.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37694143","citation_count":11,"is_preprint":false},{"pmid":"30621105","id":"PMC_30621105","title":"Polymorphisms of ABCG2 and SLC22A12 Genes Associated with Gout Risk in Vietnamese Population.","date":"2019","source":"Medicina (Kaunas, Lithuania)","url":"https://pubmed.ncbi.nlm.nih.gov/30621105","citation_count":11,"is_preprint":false},{"pmid":"36979028","id":"PMC_36979028","title":"Loss of the Kidney Urate Transporter, Urat1, Leads to Disrupted Redox Homeostasis in Mice.","date":"2023","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36979028","citation_count":10,"is_preprint":false},{"pmid":"39222901","id":"PMC_39222901","title":"Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production.","date":"2024","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/39222901","citation_count":10,"is_preprint":false},{"pmid":"12574866","id":"PMC_12574866","title":"Interspecies comparison of a gene pair with partially redundant function: the rst and kirre genes in D. virilis and D. melanogaster.","date":"2003","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/12574866","citation_count":10,"is_preprint":false},{"pmid":"24199570","id":"PMC_24199570","title":"[Effect of total saponin of Dioscorea on chronic hyperuricemia and expression of URAT1 in rats].","date":"2013","source":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica","url":"https://pubmed.ncbi.nlm.nih.gov/24199570","citation_count":10,"is_preprint":false},{"pmid":"40100301","id":"PMC_40100301","title":"Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/40100301","citation_count":9,"is_preprint":false},{"pmid":"35225677","id":"PMC_35225677","title":"Genetic Association Between SLC22A12 Variants and Susceptibility to Hyperuricemia: A Meta-Analysis.","date":"2022","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/35225677","citation_count":9,"is_preprint":false},{"pmid":"36347120","id":"PMC_36347120","title":"Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone.","date":"2022","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36347120","citation_count":9,"is_preprint":false},{"pmid":"31131560","id":"PMC_31131560","title":"Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31131560","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53337,"output_tokens":6179,"usd":0.126348,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14820,"output_tokens":3382,"usd":0.079325,"stage2_stop_reason":"end_turn"},"total_usd":0.205673,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of native hURAT1 bound with anti-gout drugs (dotinurad, benzbromarone, lesinurad, verinurad) in the inward-open state, and with urate in inward-open, outward-open, and occluded states were solved. Complemented by mutagenesis and cell-based assays, these structures reveal the mechanisms of urate reabsorption and hURAT1 inhibition, providing a structural framework for understanding the transport cycle and drug binding.\",\n      \"method\": \"Cryo-electron microscopy, site-directed mutagenesis, cell-based transport assays\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structures at multiple states, mutagenesis, and cell-based functional validation in a single rigorous study\",\n      \"pmids\": [\"40169562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PDZK1 interacts with URAT1 via the PDZ motif at the extreme C-terminal intracellular region of URAT1 and the first, second, and fourth PDZ domains of PDZK1. This interaction enhances urate transport activity (1.4-fold increase in Vmax) and increases surface expression of URAT1 at the apical membrane of renal proximal tubular cells.\",\n      \"method\": \"Yeast two-hybrid screen, in vitro binding assay, surface plasmon resonance, co-immunoprecipitation, colocalization by microscopy, urate transport assays in HEK293 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, SPR binding constants, yeast two-hybrid, functional transport assay, and localization, all in a single study with multiple orthogonal methods\",\n      \"pmids\": [\"15304510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Loss-of-function mutations in SLC22A12 encoding URAT1 cause renal hypouricemia. URAT1 is the primary reabsorptive urate transporter at the apical membrane of renal proximal tubules and is the target of uricosuric drugs (benzbromarone, probenecid) and the anti-uricosuric drug pyrazinamide in vivo, as demonstrated by pyrazinamide failing to affect urate clearance in homozygous/compound heterozygous SLC22A12 mutant patients.\",\n      \"method\": \"SLC22A12 gene sequencing in 32 patients, pharmacological loading tests (probenecid, benzbromarone, pyrazinamide), urate clearance measurements\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with defined pharmacological phenotype, gene-dosage effect, replicated across multiple patients and independent studies\",\n      \"pmids\": [\"14694169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"URAT1 expressed in MDCK cells localizes mainly to the apical membrane (as shown by GFP fusion imaging) and mediates time- and dose-dependent urate uptake with a Km of 570.7 µmol/L. Multiple uricosuric drugs (benzbromarone and metabolites, probenecid, indomethacin, salicylate, E3040) inhibit URAT1-mediated urate uptake dose-dependently with IC50 values ranging from 0.05–716 µmol/L.\",\n      \"method\": \"Stable expression in MDCK cells, urate uptake assays, GFP fusion protein localization by microscopy, pharmacological inhibition studies\",\n      \"journal\": \"Nephrology (Carlton, Vic.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional transport assay, multiple drugs characterized in stably expressing cell line\",\n      \"pmids\": [\"21272127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"URAT1 (rUrat1) in rats is localized at the apical membrane of proximal tubular epithelial cells and mediates chloride-susceptible urate transport (Km 1773 µM), inhibited by benzbromarone and trans-stimulated by lactate and pyrazinecarboxylic acid (PZA), consistent with a role in renal urate reabsorption.\",\n      \"method\": \"Gene expression in Xenopus oocytes, brush-border membrane vesicle (BBMV) transport assays, immunohistochemistry in rat kidney\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution in oocytes, BBMV assays, and immunohistochemical localization with functional characterization\",\n      \"pmids\": [\"21074513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SLC22A12 (Urat1) knockout mice show significantly higher urinary urate/creatinine ratios than wild-type mice, confirming attenuated renal urate reabsorption via Urat1. However, residual urate reabsorption remains, indicating at least one other urate reabsorptive transporter exists in the mouse kidney.\",\n      \"method\": \"Gene targeting (exons 1–4 replaced by pMC1neo-polyA), urinary urate/creatinine measurement, plasma urate measurement\",\n      \"journal\": \"Nucleosides, nucleotides & nucleic acids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean knockout mouse with defined renal phenotype; negative result (residual reabsorption) also mechanistically informative\",\n      \"pmids\": [\"20544513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"URAT1 missense mutations R406C and G444R found in Iraqi Jewish patients dramatically impair urate uptake into Xenopus oocytes. Additionally, URAT1 facilitates urate efflux (secretion), which was also abolished in the mutants, indicating URAT1 mediates bidirectional urate transport.\",\n      \"method\": \"Xenopus laevis oocyte transport assays (uptake and efflux) with wild-type and mutant URAT1\",\n      \"journal\": \"Nephrology, dialysis, transplantation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro transport reconstitution in oocytes with mutagenesis, demonstrating bidirectional transport\",\n      \"pmids\": [\"21148271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Salicylate is a transport substrate of URAT1 (Km 25.3 µM in oocytes) and also a cis-inhibitor of urate uptake (IC50 23.9 µM in HEK293-URAT1 cells). Salicylate injected into URAT1-expressing oocytes stimulates urate uptake (trans-stimulation), explaining the paradoxical dose-dependent effect of salicylate on renal urate excretion: at low doses, salicylate acts as an exchange substrate facilitating urate reabsorption; at high doses, it competitively inhibits URAT1.\",\n      \"method\": \"Radiolabeled transport assays in HEK293-URAT1 cells and Xenopus oocytes, trans-stimulation experiments\",\n      \"journal\": \"Nihon Jinzo Gakkai shi\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro transport assay in two expression systems with mechanistic kinetic analysis\",\n      \"pmids\": [\"20560471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Morin competitively inhibits hURAT1-mediated urate uptake in HEK293 cells with IC50 of 2.0 µM and Ki of 5.74 µM. hURAT1 protein is sorted to the apical membrane of transfected cells as confirmed by confocal microscopy.\",\n      \"method\": \"Transfection of HEK293 cells with hURAT1, radiolabeled urate uptake assays, confocal microscopy of GFP-tagged transporter, kinetic analysis\",\n      \"journal\": \"Drug metabolism and disposition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct transport assay with kinetic inhibition analysis and subcellular localization, single lab\",\n      \"pmids\": [\"17325024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Ancestral URAT1 proteins were computationally inferred, resurrected, and functionally assayed, revealing that URAT1 affinity for uric acid increased during primate evolution, driven by a few amino acid replacements. Human and baboon URAT1 proteins have higher affinity for uric acid than rat and mouse orthologs.\",\n      \"method\": \"Ancestral sequence reconstruction, resurrection of ancient URAT1 proteins, in vitro transport assays comparing orthologs\",\n      \"journal\": \"Molecular biology and evolution\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — functional reconstitution of resurrected proteins with transport assays, single lab\",\n      \"pmids\": [\"27352852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Functional analysis in Xenopus oocytes showed that the SLC22A12 deletion mutation 313A (deletion of residues 313D-333P) has no urate transport activity, identifying it as a loss-of-function mutation causing renal hypouricemia.\",\n      \"method\": \"Xenopus oocyte expression system with urate transport assay\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct in vitro transport assay in oocytes, single lab and single mutation tested\",\n      \"pmids\": [\"15327384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"URAT1 variants p.G366R, p.L415_G417del, and p.T467M show significantly decreased urate uptake in functional studies and are mislocalized (accumulate in the endoplasmic reticulum rather than the plasma membrane), suggesting loss-of-function via protein misfolding.\",\n      \"method\": \"Urate uptake assays, immunofluorescence colocalization with ER markers in transfected cells\",\n      \"journal\": \"European journal of human genetics : EJHG\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transport assay plus subcellular localization, single lab\",\n      \"pmids\": [\"23386035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"URAT1 is expressed on the cilia and apical surface of ventricular ependymal cells lining the lateral ventricle, dorsal/ventral third ventricle, aqueduct, and fourth ventricle in the mouse brain, suggesting a role in regulating urate levels in cerebrospinal fluid.\",\n      \"method\": \"Immunohistochemistry of wild-type and URAT1 knockout mouse brain; specificity confirmed by absence of staining in knockout\",\n      \"journal\": \"Fluids and barriers of the CNS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with KO-validated antibody specificity, single lab, functional significance inferred\",\n      \"pmids\": [\"24156345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The hURAT1 gene promoter was cloned and the transcription initiation site mapped 337 bp upstream of the ATG start codon. The minimal functional promoter is within 253 bp. Testosterone significantly increases promoter activity, suggesting hormonal regulation underlies sex-related differences in urate levels.\",\n      \"method\": \"Primer extension, 5'-RACE, promoter-luciferase reporter constructs transfected in OK cells, testosterone stimulation\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional promoter assay with hormone stimulation, single lab\",\n      \"pmids\": [\"15566944\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Genetic and pharmacological inhibition of SGLT2 enhanced fractional renal urate excretion in mice. URAT1 knockout mice demonstrated that URAT1 is required for the acute uricosuric effect of the SGLT2 inhibitor canagliflozin, placing URAT1 downstream in the luminal glucose-mediated uricosuric mechanism.\",\n      \"method\": \"Gene-targeted mouse models (Urat1-KO, Sglt2-KO, Sglt1-KO, Glut9 tubular KO), SGLT2 inhibitor treatment, renal clearance studies\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in multiple KO models, single lab\",\n      \"pmids\": [\"30427222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"URAT1 is expressed in the liver and brown adipose tissue (BAT) in addition to the kidney. In high-fat diet mice, URAT1 expression increased in BAT. Pharmacological inhibition with dotinurad (a URAT1-selective inhibitor) attenuated hepatic steatosis and BAT whitening via UCP1 activation, ameliorating insulin resistance.\",\n      \"method\": \"Western blot for URAT1 expression in liver and BAT, dotinurad treatment of HFD mice, metabolic phenotyping\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct expression localization plus pharmacological inhibition with metabolic readouts, single lab\",\n      \"pmids\": [\"34863940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"URAT1 is expressed in cardiomyocytes and functions as a uric acid transporter in this cell type. Palmitic acid increases URAT1 expression in neonatal rat cardiomyocytes and induces apoptosis, oxidative stress, and inflammatory responses via the MAPK pathway; URAT1-selective inhibition with dotinurad attenuates these effects.\",\n      \"method\": \"Western blot and functional transport assay in cardiomyocytes, palmitic acid stimulation, dotinurad treatment, HFD mouse model\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — expression and functional data in cardiomyocytes, pharmacological inhibition with pathway readout, single lab\",\n      \"pmids\": [\"37694143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"URAT1 cell-surface abundance and urate transport activity are regulated by phosphorylation of URAT1 at Thr408, stimulated by hyperinsulinemia via AKT kinase. SGK1, induced by high salt, also phosphorylates URAT1-Thr408 via the same pathway, increasing URAT1 activity. Arg405 is essential for these kinases to phosphorylate URAT1-Thr408.\",\n      \"method\": \"Kinase screening, single-cell data analysis, cell culture experiments with AKT/SGK1 inhibition and activation, URAT1 mutagenesis (Arg405, Thr408), urate transport assays in transfected cells\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — kinase screening, mutagenesis of phosphorylation site, functional transport assays, and large human cohort validation; multiple orthogonal methods in one study\",\n      \"pmids\": [\"40100301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Xanthine (but not hypoxanthine) is a substrate of URAT1, as demonstrated by uptake assays in URAT1-expressing Xenopus oocytes. Transcellular transport of xanthine in MDCKII cells co-expressing URAT1 and GLUT9 was significantly higher than in cells expressing either transporter alone or mock cells, indicating cooperative reabsorption.\",\n      \"method\": \"Radiolabeled xanthine/hypoxanthine uptake assays in Xenopus oocytes expressing URAT1 or GLUT9; transcellular transport in MDCKII cells; in vivo renal clearance in rats with dotinurad\",\n      \"journal\": \"Biological & pharmaceutical bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct substrate identification in oocyte reconstitution system, single lab, confirmed with in vivo data\",\n      \"pmids\": [\"33132325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss of Urat1/Rst in knockout mice leads to disrupted redox homeostasis, with accumulation of metabolites related to pyrimidine, fatty acid, and amino acid metabolism distinct from Oat1 and Oat3 knockouts. Systems metabolic analysis revealed compensatory processes related to reactive oxygen species handling via Vitamin C metabolism and cofactor charging reactions.\",\n      \"method\": \"Metabolomics of Urat1 knockout mice, transcriptomics, genome-scale metabolic modeling (GEM), chemoinformatics\",\n      \"journal\": \"Antioxidants (Basel, Switzerland)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO model with multi-omics phenotyping and systems analysis, single lab\",\n      \"pmids\": [\"36979028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In Urat1-Uox double knockout mice, exercise-induced AKI is associated with increased NLRP3 inflammasome activity (elevated IL-1β) and downregulation of Na+-K+-ATPase in the kidney. Xanthine oxidoreductase inhibitors (topiroxostat and allopurinol) improved renal injury and prevented EIAKI in these mice.\",\n      \"method\": \"Double KO mice (Urat1-Uox), forced swimming exercise test, Western blot for NLRP3, Na+-K+-ATPase, IL-1β; XOI treatment\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic model with defined molecular pathway via Western blot and pharmacological rescue, single lab\",\n      \"pmids\": [\"34799437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ALPK1 overexpression in transgenic mice decreased renal URAT1 protein levels, and MSU crystals inhibited URAT1 expression through upregulation of ALPK1 in human kidney-2 cells, establishing ALPK1 as a negative regulator of URAT1 protein expression.\",\n      \"method\": \"ALPK1 transgenic mice (URAT1 protein by Western blot), ALPK1 siRNA knockdown in HK-2 cells with MSU crystal stimulation\",\n      \"journal\": \"Rheumatology (Oxford, England)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, Western blot for protein level only, mechanism of regulation not detailed\",\n      \"pmids\": [\"28039413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In leptin-deficient (ob/ob) and high-fat diet mice, URAT1 (Slc22a12) protein levels are increased in the kidney without significant changes in mRNA, suggesting post-translational regulation of URAT1 protein abundance in obesity.\",\n      \"method\": \"Western blot and RT-PCR of kidney tissue from ob/ob and high-fat diet mouse models\",\n      \"journal\": \"Nucleosides, nucleotides & nucleic acids\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, correlational protein/mRNA measurement without mechanistic follow-up\",\n      \"pmids\": [\"22132989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Long-chain unsaturated omega-3 fatty acids (eicosapentaenoic acid IC50 6.0 µM, α-linolenic acid IC50 14.2 µM, docosahexaenoic acid IC50 15.2 µM) inhibit URAT1-mediated urate transport more potently than saturated fatty acids, as determined in cells transiently expressing URAT1.\",\n      \"method\": \"In vitro transport assay using cells transiently expressing URAT1, IC50 determination for 25 fatty acids\",\n      \"journal\": \"Nutrients\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic in vitro inhibition screen with IC50 values across multiple substrates, single lab\",\n      \"pmids\": [\"32486008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Rare SLC22A12 variants that reduce URAT1 urate transport activity account for >10% of heritability in serum urate levels (missing heritability), as demonstrated by functional transport assays on identified rare variants combined with population genetic analysis.\",\n      \"method\": \"Whole genome sequencing (ToMMo cohort), functional urate uptake assays on identified rare variants, variance component analysis\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transport assays on variants combined with population genetics, single lab\",\n      \"pmids\": [\"32005656\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"URAT1 (SLC22A12) is a urate-anion exchanger localized at the apical membrane of renal proximal tubular cells that mediates the majority of renal urate reabsorption via an electroneutral exchange mechanism; its transport activity is regulated by AKT/SGK1-mediated phosphorylation at Thr408 (stimulated by hyperinsulinemia and high salt), enhanced by interaction with the scaffold protein PDZK1 (which increases surface expression and Vmax), and inhibited competitively by uricosuric drugs (benzbromarone, probenecid, lesinurad, dotinurad, verinurad) whose binding modes have been resolved by cryo-EM structures in multiple conformational states; URAT1 also transports salicylate and xanthine as substrates, is additionally expressed in ependymal cells, cardiomyocytes, liver, and brown adipose tissue, and loss-of-function mutations cause renal hypouricemia type 1.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC22A12 (URAT1) is the principal apical urate-anion exchanger of the renal proximal tubule and the central determinant of renal urate reabsorption [#2, #3]. It mediates electrogenic, chloride-sensitive urate transport that is bidirectional, supporting both reabsorptive uptake and efflux, and is trans-stimulated by intracellular monocarboxylates such as lactate and pyrazinecarboxylate [#4, #6]. Cryo-EM structures captured in inward-open, outward-open, and occluded states define the transport cycle and the binding modes of urate and uricosuric inhibitors [#0]. Beyond urate, URAT1 transports salicylate and xanthine, the latter cooperatively with GLUT9 in transcellular assays; salicylate behaves as both an exchange substrate (trans-stimulating reabsorption at low dose) and a competitive inhibitor at high dose [#7, #18]. Transport activity is tuned post-translationally: PDZK1 binds the C-terminal PDZ motif of URAT1 to raise apical surface expression and Vmax [#1], while AKT and high-salt-induced SGK1 phosphorylate URAT1 at Thr408 (dependent on Arg405) to increase surface abundance and activity [#17]. Loss-of-function mutations in SLC22A12 cause renal hypouricemia type 1, frequently through impaired transport or ER retention of misfolded protein [#2, #11]. Although best characterized in kidney, URAT1 is also expressed in ependymal cilia, cardiomyocytes, liver, and brown adipose tissue, where its activity has been linked to local metabolic and inflammatory responses [#12, #15, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that URAT1 is the primary renal reabsorptive urate transporter and the in vivo target of uricosuric and anti-uricosuric drugs converted a candidate transporter into the genetic and pharmacological linchpin of urate handling.\",\n      \"evidence\": \"SLC22A12 sequencing in renal hypouricemia patients with pharmacological loading tests (probenecid, benzbromarone, pyrazinamide)\",\n      \"pmids\": [\"14694169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the exchange mechanism or counter-ion at molecular level\", \"Residual reabsorption pathway not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identifying PDZK1 as a scaffold partner answered how URAT1 is held at and enriched on the apical membrane, linking trafficking to transport capacity.\",\n      \"evidence\": \"Yeast two-hybrid, SPR, reciprocal Co-IP, colocalization, and urate transport assays in HEK293 cells\",\n      \"pmids\": [\"15304510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Vmax increase modest (1.4-fold); physiological magnitude in vivo unclear\", \"Whether PDZK1 regulation is dynamically modulated not addressed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapping the promoter and showing testosterone-stimulated activity provided a transcriptional basis for sex differences in serum urate.\",\n      \"evidence\": \"Primer extension, 5'-RACE, and promoter-luciferase reporters with testosterone stimulation in OK cells\",\n      \"pmids\": [\"15566944\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcription factor mediating testosterone response not identified\", \"In vivo relevance to human sex differences not established\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Oocyte and BBMV reconstitution defined URAT1 as a chloride-sensitive, monocarboxylate trans-stimulated urate transporter, and knockout mice confirmed its role while revealing a second reabsorptive pathway.\",\n      \"evidence\": \"Xenopus oocyte and brush-border vesicle transport assays, immunohistochemistry, and Urat1 knockout mouse urinary phenotyping\",\n      \"pmids\": [\"21074513\", \"20544513\", \"21148271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the residual urate reabsorptive transporter unknown\", \"Endogenous counter-substrate driving exchange in vivo not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating salicylate as both a transported substrate and a dose-dependent modulator explained the long-standing paradox of biphasic salicylate effects on urate excretion.\",\n      \"evidence\": \"Radiolabeled transport and trans-stimulation assays in HEK293-URAT1 and Xenopus oocytes\",\n      \"pmids\": [\"20560471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dual substrate/inhibitor behavior not resolved at this stage\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showing that disease mutants are retained in the ER established protein misfolding/mistrafficking as a mechanism of loss-of-function, beyond simple loss of intrinsic transport.\",\n      \"evidence\": \"Urate uptake assays plus immunofluorescence colocalization with ER markers for p.G366R, p.L415_G417del, p.T467M\",\n      \"pmids\": [\"23386035\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether folding can be pharmacologically rescued untested\", \"Generality across all hypouricemia variants unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Detecting URAT1 on ependymal cilia broadened its role beyond kidney to potential CSF urate regulation.\",\n      \"evidence\": \"KO-validated immunohistochemistry of mouse brain ventricular surfaces\",\n      \"pmids\": [\"24156345\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional transport at ependyma not directly measured\", \"Physiological consequence for CSF urate unestablished\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Ancestral resurrection showed URAT1 urate affinity rose during primate evolution, framing high urate reabsorption as a derived primate trait.\",\n      \"evidence\": \"Ancestral sequence reconstruction and transport assays comparing resurrected and extant orthologs\",\n      \"pmids\": [\"27352852\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Selective advantage driving affinity increase inferred, not demonstrated\", \"Specific residues only partially mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extending the substrate repertoire to xanthine and showing GLUT9 cooperativity, plus population-scale rare-variant analysis, connected URAT1 transport directly to heritable serum urate variation.\",\n      \"evidence\": \"Oocyte/MDCKII transcellular xanthine assays and functional assays on rare variants from whole-genome sequencing with variance component analysis\",\n      \"pmids\": [\"33132325\", \"32005656\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological importance of xanthine transport relative to urate unclear\", \"Functional effect of many rare variants still uncharacterized\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cryo-EM in multiple conformational states and identification of AKT/SGK1 phosphorylation at Thr408 together provided the structural transport cycle and a signaling mechanism linking hyperinsulinemia and salt to elevated urate.\",\n      \"evidence\": \"Cryo-EM with mutagenesis and transport assays; kinase screening, phospho-site mutagenesis (Arg405, Thr408), and human cohort validation\",\n      \"pmids\": [\"40169562\", \"40100301\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphatase counter-regulating Thr408 not identified\", \"Structures of phosphorylated state not resolved\", \"Integration of PDZK1 scaffolding into structural model incomplete\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How URAT1 contributes mechanistically to extrarenal tissues (cardiomyocyte injury, hepatic steatosis, BAT thermogenesis, redox homeostasis) and how its surface abundance is dynamically controlled remain incompletely defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transport function in liver/BAT not measured in situ\", \"Causal chain from URAT1 activity to MAPK/NLRP3/UCP1 outcomes unresolved\", \"Mechanisms of post-translational protein-level regulation in obesity not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [2, 3, 4, 6, 7, 18]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [4, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 4, 8]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 3, 4, 18]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [7, 18]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PDZK1\", \"GLUT9\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}